. . . . . . "klinisch onderzoek"@nl . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . "clinical trial"@en . . . . . . . . . . . . . . . . . . . . . . "NCT01198158" . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "77"^^ . . . . . "Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy"@en . . . . . . . . . . . . . "Randomized Phase III Trial Comparing Everolimus Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment With Tyrosine Kinase Inhibitors"@en . "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . . . "2017-12-15T00:00:00Z"^^ . . . . . . . "Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy"@en . . . . . "Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy"@en . . . "18"^^ . . . . . . . . . . "2010-09-15T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . .